Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 150.75
+2.00 (1.34%)
At close: Apr 21, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 200.25 billion as of April 21, 2026. Its market cap has decreased by -30.96% in one year.
Market Cap
200.25B
Enterprise Value
241.32B
Revenue
88.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
150.75
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 200.25B, a decrease of -11.68%. That is a compound annual growth rate of -3.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 200.25B | -12.43% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 415.35B |
| J. B. Chemicals & Pharmaceuticals | 320.69B |
| AstraZeneca Pharma India | 212.72B |
| Granules India | 162.16B |
| Rubicon Research | 148.09B |
| Jubilant Pharmova | 144.39B |
| Caplin Point Laboratories | 134.73B |
| CORONA Remedies | 99.05B |